Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Anti-infectious Disease Drugs Market Growth 2022-2028

  • LP 4978084
  • 106 Pages
  • July 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Anti-infectious Disease Drugs will have significant change from previous year. According to our (LP Information) latest study, the global Anti-infectious Disease Drugs market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Anti-infectious Disease Drugs market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States Anti-infectious Disease Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Anti-infectious Disease Drugs market, reaching US$ million by the year 2028. As for the Europe Anti-infectious Disease Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main Anti-infectious Disease Drugs players cover Aridis Pharmaceuticals, AiCuris, Sandoz, and Anhui Jingfang Medical Industry Co.,Ltd, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-infectious Disease Drugs market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Antibacterial Drugs

Antifungal Drugs

Antiviral Drugs

Antiparasitic Drugs

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Institute of Medicine

Clinic

Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Aridis Pharmaceuticals

AiCuris

Sandoz

Anhui Jingfang Medical Industry Co.,Ltd

Beijing Double-Crane Pharmaceutical Co., Ltd.

Abbott

Spero Therapeutics

Adlyfe, Inc.

Advanced Life Sciences Holdings, Inc.

Affinium Pharmaceuticals

APP Pharmaceuticals

Aquapharm Biodiscovery

Basilea Pharmaceutica AG

Biophage Pharma, Inc.

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-infectious Disease Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Anti-infectious Disease Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Anti-infectious Disease Drugs by Country/Region, 2017, 2022 & 2028

2.2 Anti-infectious Disease Drugs Segment by Type

2.2.1 Antibacterial Drugs

2.2.2 Antifungal Drugs

2.2.3 Antiviral Drugs

2.2.4 Antiparasitic Drugs

2.3 Anti-infectious Disease Drugs Sales by Type

2.3.1 Global Anti-infectious Disease Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Anti-infectious Disease Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Anti-infectious Disease Drugs Sale Price by Type (2017-2022)

2.4 Anti-infectious Disease Drugs Segment by Application

2.4.1 Hospital

2.4.2 Institute of Medicine

2.4.3 Clinic

2.4.4 Others

2.5 Anti-infectious Disease Drugs Sales by Application

2.5.1 Global Anti-infectious Disease Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Anti-infectious Disease Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Anti-infectious Disease Drugs Sale Price by Application (2017-2022)

3 Global Anti-infectious Disease Drugs by Company

3.1 Global Anti-infectious Disease Drugs Breakdown Data by Company

3.1.1 Global Anti-infectious Disease Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Anti-infectious Disease Drugs Sales Market Share by Company (2020-2022)

3.2 Global Anti-infectious Disease Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Anti-infectious Disease Drugs Revenue by Company (2020-2022)

3.2.2 Global Anti-infectious Disease Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Anti-infectious Disease Drugs Sale Price by Company

3.4 Key Manufacturers Anti-infectious Disease Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Anti-infectious Disease Drugs Product Location Distribution

3.4.2 Players Anti-infectious Disease Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Anti-infectious Disease Drugs by Geographic Region

4.1 World Historic Anti-infectious Disease Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Anti-infectious Disease Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Anti-infectious Disease Drugs Annual Revenue by Geographic Region

4.2 World Historic Anti-infectious Disease Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Anti-infectious Disease Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Anti-infectious Disease Drugs Annual Revenue by Country/Region

4.3 Americas Anti-infectious Disease Drugs Sales Growth

4.4 APAC Anti-infectious Disease Drugs Sales Growth

4.5 Europe Anti-infectious Disease Drugs Sales Growth

4.6 Middle East & Africa Anti-infectious Disease Drugs Sales Growth

5 Americas

5.1 Americas Anti-infectious Disease Drugs Sales by Country

5.1.1 Americas Anti-infectious Disease Drugs Sales by Country (2017-2022)

5.1.2 Americas Anti-infectious Disease Drugs Revenue by Country (2017-2022)

5.2 Americas Anti-infectious Disease Drugs Sales by Type

5.3 Americas Anti-infectious Disease Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Anti-infectious Disease Drugs Sales by Region

6.1.1 APAC Anti-infectious Disease Drugs Sales by Region (2017-2022)

6.1.2 APAC Anti-infectious Disease Drugs Revenue by Region (2017-2022)

6.2 APAC Anti-infectious Disease Drugs Sales by Type

6.3 APAC Anti-infectious Disease Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Anti-infectious Disease Drugs by Country

7.1.1 Europe Anti-infectious Disease Drugs Sales by Country (2017-2022)

7.1.2 Europe Anti-infectious Disease Drugs Revenue by Country (2017-2022)

7.2 Europe Anti-infectious Disease Drugs Sales by Type

7.3 Europe Anti-infectious Disease Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Anti-infectious Disease Drugs by Country

8.1.1 Middle East & Africa Anti-infectious Disease Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Anti-infectious Disease Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Anti-infectious Disease Drugs Sales by Type

8.3 Middle East & Africa Anti-infectious Disease Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Anti-infectious Disease Drugs

10.3 Manufacturing Process Analysis of Anti-infectious Disease Drugs

10.4 Industry Chain Structure of Anti-infectious Disease Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Anti-infectious Disease Drugs Distributors

11.3 Anti-infectious Disease Drugs Customer

12 World Forecast Review for Anti-infectious Disease Drugs by Geographic Region

12.1 Global Anti-infectious Disease Drugs Market Size Forecast by Region

12.1.1 Global Anti-infectious Disease Drugs Forecast by Region (2023-2028)

12.1.2 Global Anti-infectious Disease Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Anti-infectious Disease Drugs Forecast by Type

12.7 Global Anti-infectious Disease Drugs Forecast by Application

13 Key Players Analysis

13.1 Aridis Pharmaceuticals

13.1.1 Aridis Pharmaceuticals Company Information

13.1.2 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Offered

13.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Aridis Pharmaceuticals Main Business Overview

13.1.5 Aridis Pharmaceuticals Latest Developments

13.2 AiCuris

13.2.1 AiCuris Company Information

13.2.2 AiCuris Anti-infectious Disease Drugs Product Offered

13.2.3 AiCuris Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 AiCuris Main Business Overview

13.2.5 AiCuris Latest Developments

13.3 Sandoz

13.3.1 Sandoz Company Information

13.3.2 Sandoz Anti-infectious Disease Drugs Product Offered

13.3.3 Sandoz Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sandoz Main Business Overview

13.3.5 Sandoz Latest Developments

13.4 Anhui Jingfang Medical Industry Co.,Ltd

13.4.1 Anhui Jingfang Medical Industry Co.,Ltd Company Information

13.4.2 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Offered

13.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Anhui Jingfang Medical Industry Co.,Ltd Main Business Overview

13.4.5 Anhui Jingfang Medical Industry Co.,Ltd Latest Developments

13.5 Beijing Double-Crane Pharmaceutical Co., Ltd.

13.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Company Information

13.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Offered

13.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Main Business Overview

13.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Latest Developments

13.6 Abbott

13.6.1 Abbott Company Information

13.6.2 Abbott Anti-infectious Disease Drugs Product Offered

13.6.3 Abbott Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Abbott Main Business Overview

13.6.5 Abbott Latest Developments

13.7 Spero Therapeutics

13.7.1 Spero Therapeutics Company Information

13.7.2 Spero Therapeutics Anti-infectious Disease Drugs Product Offered

13.7.3 Spero Therapeutics Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Spero Therapeutics Main Business Overview

13.7.5 Spero Therapeutics Latest Developments

13.8 Adlyfe, Inc.

13.8.1 Adlyfe, Inc. Company Information

13.8.2 Adlyfe, Inc. Anti-infectious Disease Drugs Product Offered

13.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Adlyfe, Inc. Main Business Overview

13.8.5 Adlyfe, Inc. Latest Developments

13.9 Advanced Life Sciences Holdings, Inc.

13.9.1 Advanced Life Sciences Holdings, Inc. Company Information

13.9.2 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Offered

13.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Advanced Life Sciences Holdings, Inc. Main Business Overview

13.9.5 Advanced Life Sciences Holdings, Inc. Latest Developments

13.10 Affinium Pharmaceuticals

13.10.1 Affinium Pharmaceuticals Company Information

13.10.2 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Offered

13.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Affinium Pharmaceuticals Main Business Overview

13.10.5 Affinium Pharmaceuticals Latest Developments

13.11 APP Pharmaceuticals

13.11.1 APP Pharmaceuticals Company Information

13.11.2 APP Pharmaceuticals Anti-infectious Disease Drugs Product Offered

13.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 APP Pharmaceuticals Main Business Overview

13.11.5 APP Pharmaceuticals Latest Developments

13.12 Aquapharm Biodiscovery

13.12.1 Aquapharm Biodiscovery Company Information

13.12.2 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Offered

13.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Aquapharm Biodiscovery Main Business Overview

13.12.5 Aquapharm Biodiscovery Latest Developments

13.13 Basilea Pharmaceutica AG

13.13.1 Basilea Pharmaceutica AG Company Information

13.13.2 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Offered

13.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 Basilea Pharmaceutica AG Main Business Overview

13.13.5 Basilea Pharmaceutica AG Latest Developments

13.14 Biophage Pharma, Inc.

13.14.1 Biophage Pharma, Inc. Company Information

13.14.2 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Offered

13.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Biophage Pharma, Inc. Main Business Overview

13.14.5 Biophage Pharma, Inc. Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Anti-infectious Disease Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Anti-infectious Disease Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Antibacterial Drugs

Table 4. Major Players of Antifungal Drugs

Table 5. Major Players of Antiviral Drugs

Table 6. Major Players of Antiparasitic Drugs

Table 7. Global Anti-infectious Disease Drugs Sales by Type (2017-2022) & (K Units)

Table 8. Global Anti-infectious Disease Drugs Sales Market Share by Type (2017-2022)

Table 9. Global Anti-infectious Disease Drugs Revenue by Type (2017-2022) & ($ million)

Table 10. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2017-2022)

Table 11. Global Anti-infectious Disease Drugs Sale Price by Type (2017-2022) & (US$/Unit)

Table 12. Global Anti-infectious Disease Drugs Sales by Application (2017-2022) & (K Units)

Table 13. Global Anti-infectious Disease Drugs Sales Market Share by Application (2017-2022)

Table 14. Global Anti-infectious Disease Drugs Revenue by Application (2017-2022)

Table 15. Global Anti-infectious Disease Drugs Revenue Market Share by Application (2017-2022)

Table 16. Global Anti-infectious Disease Drugs Sale Price by Application (2017-2022) & (US$/Unit)

Table 17. Global Anti-infectious Disease Drugs Sales by Company (2020-2022) & (K Units)

Table 18. Global Anti-infectious Disease Drugs Sales Market Share by Company (2020-2022)

Table 19. Global Anti-infectious Disease Drugs Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Anti-infectious Disease Drugs Revenue Market Share by Company (2020-2022)

Table 21. Global Anti-infectious Disease Drugs Sale Price by Company (2020-2022) & (US$/Unit)

Table 22. Key Manufacturers Anti-infectious Disease Drugs Producing Area Distribution and Sales Area

Table 23. Players Anti-infectious Disease Drugs Products Offered

Table 24. Anti-infectious Disease Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Anti-infectious Disease Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 28. Global Anti-infectious Disease Drugs Sales Market Share Geographic Region (2017-2022)

Table 29. Global Anti-infectious Disease Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Anti-infectious Disease Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Anti-infectious Disease Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 32. Global Anti-infectious Disease Drugs Sales Market Share by Country/Region (2017-2022)

Table 33. Global Anti-infectious Disease Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Anti-infectious Disease Drugs Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Anti-infectious Disease Drugs Sales by Country (2017-2022) & (K Units)

Table 36. Americas Anti-infectious Disease Drugs Sales Market Share by Country (2017-2022)

Table 37. Americas Anti-infectious Disease Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Anti-infectious Disease Drugs Revenue Market Share by Country (2017-2022)

Table 39. Americas Anti-infectious Disease Drugs Sales by Type (2017-2022) & (K Units)

Table 40. Americas Anti-infectious Disease Drugs Sales Market Share by Type (2017-2022)

Table 41. Americas Anti-infectious Disease Drugs Sales by Application (2017-2022) & (K Units)

Table 42. Americas Anti-infectious Disease Drugs Sales Market Share by Application (2017-2022)

Table 43. APAC Anti-infectious Disease Drugs Sales by Region (2017-2022) & (K Units)

Table 44. APAC Anti-infectious Disease Drugs Sales Market Share by Region (2017-2022)

Table 45. APAC Anti-infectious Disease Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Anti-infectious Disease Drugs Revenue Market Share by Region (2017-2022)

Table 47. APAC Anti-infectious Disease Drugs Sales by Type (2017-2022) & (K Units)

Table 48. APAC Anti-infectious Disease Drugs Sales Market Share by Type (2017-2022)

Table 49. APAC Anti-infectious Disease Drugs Sales by Application (2017-2022) & (K Units)

Table 50. APAC Anti-infectious Disease Drugs Sales Market Share by Application (2017-2022)

Table 51. Europe Anti-infectious Disease Drugs Sales by Country (2017-2022) & (K Units)

Table 52. Europe Anti-infectious Disease Drugs Sales Market Share by Country (2017-2022)

Table 53. Europe Anti-infectious Disease Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Anti-infectious Disease Drugs Revenue Market Share by Country (2017-2022)

Table 55. Europe Anti-infectious Disease Drugs Sales by Type (2017-2022) & (K Units)

Table 56. Europe Anti-infectious Disease Drugs Sales Market Share by Type (2017-2022)

Table 57. Europe Anti-infectious Disease Drugs Sales by Application (2017-2022) & (K Units)

Table 58. Europe Anti-infectious Disease Drugs Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Anti-infectious Disease Drugs Sales by Country (2017-2022) & (K Units)

Table 60. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Anti-infectious Disease Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Anti-infectious Disease Drugs Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Anti-infectious Disease Drugs Sales by Type (2017-2022) & (K Units)

Table 64. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Anti-infectious Disease Drugs Sales by Application (2017-2022) & (K Units)

Table 66. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Anti-infectious Disease Drugs

Table 68. Key Market Challenges & Risks of Anti-infectious Disease Drugs

Table 69. Key Industry Trends of Anti-infectious Disease Drugs

Table 70. Anti-infectious Disease Drugs Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Anti-infectious Disease Drugs Distributors List

Table 73. Anti-infectious Disease Drugs Customer List

Table 74. Global Anti-infectious Disease Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 75. Global Anti-infectious Disease Drugs Sales Market Forecast by Region

Table 76. Global Anti-infectious Disease Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Anti-infectious Disease Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Anti-infectious Disease Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 79. Americas Anti-infectious Disease Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Anti-infectious Disease Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 81. APAC Anti-infectious Disease Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Anti-infectious Disease Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Europe Anti-infectious Disease Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Anti-infectious Disease Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Middle East & Africa Anti-infectious Disease Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Anti-infectious Disease Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 87. Global Anti-infectious Disease Drugs Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Anti-infectious Disease Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Anti-infectious Disease Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Anti-infectious Disease Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 91. Global Anti-infectious Disease Drugs Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Anti-infectious Disease Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Anti-infectious Disease Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 94. Aridis Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 95. Aridis Pharmaceuticals Anti-infectious Disease Drugs Product Offered

Table 96. Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 97. Aridis Pharmaceuticals Main Business

Table 98. Aridis Pharmaceuticals Latest Developments

Table 99. AiCuris Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 100. AiCuris Anti-infectious Disease Drugs Product Offered

Table 101. AiCuris Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 102. AiCuris Main Business

Table 103. AiCuris Latest Developments

Table 104. Sandoz Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 105. Sandoz Anti-infectious Disease Drugs Product Offered

Table 106. Sandoz Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 107. Sandoz Main Business

Table 108. Sandoz Latest Developments

Table 109. Anhui Jingfang Medical Industry Co.,Ltd Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 110. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product Offered

Table 111. Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 112. Anhui Jingfang Medical Industry Co.,Ltd Main Business

Table 113. Anhui Jingfang Medical Industry Co.,Ltd Latest Developments

Table 114. Beijing Double-Crane Pharmaceutical Co., Ltd. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 115. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product Offered

Table 116. Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 117. Beijing Double-Crane Pharmaceutical Co., Ltd. Main Business

Table 118. Beijing Double-Crane Pharmaceutical Co., Ltd. Latest Developments

Table 119. Abbott Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 120. Abbott Anti-infectious Disease Drugs Product Offered

Table 121. Abbott Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 122. Abbott Main Business

Table 123. Abbott Latest Developments

Table 124. Spero Therapeutics Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 125. Spero Therapeutics Anti-infectious Disease Drugs Product Offered

Table 126. Spero Therapeutics Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 127. Spero Therapeutics Main Business

Table 128. Spero Therapeutics Latest Developments

Table 129. Adlyfe, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 130. Adlyfe, Inc. Anti-infectious Disease Drugs Product Offered

Table 131. Adlyfe, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 132. Adlyfe, Inc. Main Business

Table 133. Adlyfe, Inc. Latest Developments

Table 134. Advanced Life Sciences Holdings, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 135. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product Offered

Table 136. Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 137. Advanced Life Sciences Holdings, Inc. Main Business

Table 138. Advanced Life Sciences Holdings, Inc. Latest Developments

Table 139. Affinium Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 140. Affinium Pharmaceuticals Anti-infectious Disease Drugs Product Offered

Table 141. Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 142. Affinium Pharmaceuticals Main Business

Table 143. Affinium Pharmaceuticals Latest Developments

Table 144. APP Pharmaceuticals Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 145. APP Pharmaceuticals Anti-infectious Disease Drugs Product Offered

Table 146. APP Pharmaceuticals Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 147. APP Pharmaceuticals Main Business

Table 148. APP Pharmaceuticals Latest Developments

Table 149. Aquapharm Biodiscovery Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 150. Aquapharm Biodiscovery Anti-infectious Disease Drugs Product Offered

Table 151. Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 152. Aquapharm Biodiscovery Main Business

Table 153. Aquapharm Biodiscovery Latest Developments

Table 154. Basilea Pharmaceutica AG Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 155. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product Offered

Table 156. Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 157. Basilea Pharmaceutica AG Main Business

Table 158. Basilea Pharmaceutica AG Latest Developments

Table 159. Biophage Pharma, Inc. Basic Information, Anti-infectious Disease Drugs Manufacturing Base, Sales Area and Its Competitors

Table 160. Biophage Pharma, Inc. Anti-infectious Disease Drugs Product Offered

Table 161. Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 162. Biophage Pharma, Inc. Main Business

Table 163. Biophage Pharma, Inc. Latest Developments

List of Figures

Figure 1. Picture of Anti-infectious Disease Drugs

Figure 2. Anti-infectious Disease Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Anti-infectious Disease Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Anti-infectious Disease Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Anti-infectious Disease Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Antibacterial Drugs

Figure 10. Product Picture of Antifungal Drugs

Figure 11. Product Picture of Antiviral Drugs

Figure 12. Product Picture of Antiparasitic Drugs

Figure 13. Global Anti-infectious Disease Drugs Sales Market Share by Type in 2021

Figure 14. Global Anti-infectious Disease Drugs Revenue Market Share by Type (2017-2022)

Figure 15. Anti-infectious Disease Drugs Consumed in Hospital

Figure 16. Global Anti-infectious Disease Drugs Market: Hospital (2017-2022) & (K Units)

Figure 17. Anti-infectious Disease Drugs Consumed in Institute of Medicine

Figure 18. Global Anti-infectious Disease Drugs Market: Institute of Medicine (2017-2022) & (K Units)

Figure 19. Anti-infectious Disease Drugs Consumed in Clinic

Figure 20. Global Anti-infectious Disease Drugs Market: Clinic (2017-2022) & (K Units)

Figure 21. Anti-infectious Disease Drugs Consumed in Others

Figure 22. Global Anti-infectious Disease Drugs Market: Others (2017-2022) & (K Units)

Figure 23. Global Anti-infectious Disease Drugs Sales Market Share by Application (2017-2022)

Figure 24. Global Anti-infectious Disease Drugs Revenue Market Share by Application in 2021

Figure 25. Anti-infectious Disease Drugs Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Anti-infectious Disease Drugs Revenue Market Share by Company in 2021

Figure 27. Global Anti-infectious Disease Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Anti-infectious Disease Drugs Revenue Market Share by Geographic Region in 2021

Figure 29. Global Anti-infectious Disease Drugs Sales Market Share by Region (2017-2022)

Figure 30. Global Anti-infectious Disease Drugs Revenue Market Share by Country/Region in 2021

Figure 31. Americas Anti-infectious Disease Drugs Sales 2017-2022 (K Units)

Figure 32. Americas Anti-infectious Disease Drugs Revenue 2017-2022 ($ Millions)

Figure 33. APAC Anti-infectious Disease Drugs Sales 2017-2022 (K Units)

Figure 34. APAC Anti-infectious Disease Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Europe Anti-infectious Disease Drugs Sales 2017-2022 (K Units)

Figure 36. Europe Anti-infectious Disease Drugs Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Anti-infectious Disease Drugs Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Anti-infectious Disease Drugs Revenue 2017-2022 ($ Millions)

Figure 39. Americas Anti-infectious Disease Drugs Sales Market Share by Country in 2021

Figure 40. Americas Anti-infectious Disease Drugs Revenue Market Share by Country in 2021

Figure 41. United States Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Anti-infectious Disease Drugs Sales Market Share by Region in 2021

Figure 46. APAC Anti-infectious Disease Drugs Revenue Market Share by Regions in 2021

Figure 47. China Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Anti-infectious Disease Drugs Sales Market Share by Country in 2021

Figure 54. Europe Anti-infectious Disease Drugs Revenue Market Share by Country in 2021

Figure 55. Germany Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Anti-infectious Disease Drugs Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Anti-infectious Disease Drugs Revenue Market Share by Country in 2021

Figure 62. Egypt Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Anti-infectious Disease Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Anti-infectious Disease Drugs in 2021

Figure 68. Manufacturing Process Analysis of Anti-infectious Disease Drugs

Figure 69. Industry Chain Structure of Anti-infectious Disease Drugs

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370